Serving hundreds of leading biopharmaceutical companies globally:

Generated: October 15, 2018

DrugPatentWatch Database Preview

Hydralazine hydrochloride; hydrochlorothiazide - Generic Drug Details

« Back to Dashboard

What are the generic sources for hydralazine hydrochloride; hydrochlorothiazide and what is the scope of hydralazine hydrochloride; hydrochlorothiazide freedom to operate?

Hydralazine hydrochloride; hydrochlorothiazide is the generic ingredient in twenty-one branded drugs marketed by Novartis, Par Pharm, Solvay, Superpharm, Watson Labs, Ivax Pharms, Chartwell Rx, Ivax Sub Teva Pharms, Mylan, Sandoz, Sun Pharm Industries, and Lederle, and is included in thirty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for hydralazine hydrochloride; hydrochlorothiazide.

Summary for hydralazine hydrochloride; hydrochlorothiazide

US Patents:	0
Tradenames:	21
Applicants:	12
NDAs:	36
Drug Master File Entries:	20
Bulk Api Vendors:	1
Clinical Trials:	3
DailyMed Link:	hydralazine hydrochloride; hydrochlorothiazide at DailyMed

Synonyms for hydralazine hydrochloride; hydrochlorothiazide

C8H8N4.C7H8ClN3O4S2.HCl
LS-178474
SCHEMBL9374288

US Patents and Regulatory Information for hydralazine hydrochloride; hydrochlorothiazide

+ Get email alerts for changes to this table

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ivax Sub Teva Pharms	HYDROSERPINE PLUS (R-H-H)	hydralazine hydrochloride; hydrochlorothiazide; reserpine	TABLET;ORAL	083877-001	Approved Prior to Jan 1, 1982		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Novartis	APRESAZIDE	hydralazine hydrochloride; hydrochlorothiazide	CAPSULE;ORAL	084811-001	Approved Prior to Jan 1, 1982		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Watson Labs	HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE	hydralazine hydrochloride; hydrochlorothiazide	CAPSULE;ORAL	085440-001	Mar 4, 1982		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Ivax Pharms	HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 25/25	hydralazine hydrochloride; hydrochlorothiazide	CAPSULE;ORAL	088356-001	Apr 10, 1984		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Novartis	APRESOLINE-ESIDRIX	hydralazine hydrochloride; hydrochlorothiazide	TABLET;ORAL	012026-002	Approved Prior to Jan 1, 1982		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Ivax Sub Teva Pharms	HYDRALAZINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE AND RESERPINE	hydralazine hydrochloride; hydrochlorothiazide; reserpine	TABLET;ORAL	084291-001	Approved Prior to Jan 1, 1982		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Sun Pharm Industries	RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE	hydralazine hydrochloride; hydrochlorothiazide; reserpine	TABLET;ORAL	088570-001	Apr 10, 1984		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust

Chubb

Accenture

Citi

Covington

Mallinckrodt

Fish and Richardson

Julphar

Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.